BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 25398090)

  • 1. Evaluation of antibody response of killed and live vaccines against porcine epidemic diarrhea virus in a field study.
    Paudel S; Park JE; Jang H; Hyun BH; Yang DG; Shin HJ
    Vet Q; 2014; 34(4):194-200. PubMed ID: 25398090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen.
    Makadiya N; Brownlie R; van den Hurk J; Berube N; Allan B; Gerdts V; Zakhartchouk A
    Virol J; 2016 Apr; 13():57. PubMed ID: 27036203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of genogroup 1 based porcine epidemic diarrhea live vaccine against genogroup 2 field strain in Japan.
    Sato T; Oroku K; Ohshima Y; Furuya Y; Sasakawa C
    Virol J; 2018 Feb; 15(1):28. PubMed ID: 29394943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum neutralization and enzyme-linked immunosorbent assay on sera from porcine epidemic diarrhea virus vaccinated pigs.
    Paudel S; Park JE; Jang H; Shin HJ
    Vet Q; 2014; 34(4):218-23. PubMed ID: 25415042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the safety and efficacy of an attenuated live vaccine based on highly virulent genotype 2b porcine epidemic diarrhea virus in nursing piglets.
    Jang G; Won H; Lee DU; Noh YH; Lee SC; Choi HW; Yoon IJ; Lee YJ; Sang Yoo H; Lee C
    Vet Microbiol; 2019 Apr; 231():120-128. PubMed ID: 30955799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets.
    Baek PS; Choi HW; Lee S; Yoon IJ; Lee YJ; Lee du S; Lee S; Lee C
    Vet Immunol Immunopathol; 2016 Jun; 174():45-9. PubMed ID: 27185262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Booster Vaccination with Inactivated Porcine Epidemic Diarrhea Virus on Neutralizing Antibody Response in Mammary Secretions.
    Gillespie T; Song Q; Inskeep M; Stone S; Murtaugh MP
    Viral Immunol; 2018; 31(1):62-68. PubMed ID: 28783456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of orally administered porcine epidemic diarrhea vaccine-loaded hydroxypropyl methylcellulose phthalate microspheres and RANKL-secreting L. lactis.
    Choe S; Song S; Piao D; Park GN; Shin J; Choi YJ; Kang SK; Cha RM; Hyun BH; Park BK; An DJ
    Vet Microbiol; 2020 Mar; 242():108604. PubMed ID: 32122610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly (d,l-lactide-co-glycolide) nanoparticle-entrapped vaccine induces a protective immune response against porcine epidemic diarrhea virus infection in piglets.
    Li B; Du L; Yu Z; Sun B; Xu X; Fan B; Guo R; Yuan W; He K
    Vaccine; 2017 Dec; 35(50):7010-7017. PubMed ID: 29102169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with porcine epidemic diarrhea virus harbouring Fc domain of IgG enhances antibody production in pigs.
    Park JE; Jang H; Kim JH; Hyun BH; Shin HJ
    Vet Q; 2020 Dec; 40(1):183-189. PubMed ID: 32448096
    [No Abstract]   [Full Text] [Related]  

  • 11. Porcine epidemic diarrhea vaccine evaluation using a newly isolated strain from Korea.
    Park JE; Kang KJ; Ryu JH; Park JY; Jang H; Sung DJ; Kang JG; Shin HJ
    Vet Microbiol; 2018 Jul; 221():19-26. PubMed ID: 29981703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemic strain YC2014 of porcine epidemic diarrhea virus could provide piglets against homologous challenge.
    Lin H; Chen L; Gao L; Yuan X; Ma Z; Fan H
    Virol J; 2016 Apr; 13():68. PubMed ID: 27103490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy of a commercial inactivated genogroup 2b-based porcine epidemic diarrhea virus (PEDV) vaccine and experimental live genogroup 1b exposure against 2b challenge.
    Opriessnig T; Gerber PF; Shen H; de Castro AMMG; Zhang J; Chen Q; Halbur P
    Vet Res; 2017 Oct; 48(1):69. PubMed ID: 29073936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions.
    Song Q; Stone S; Drebes D; Greiner LL; Dvorak CMT; Murtaugh MP
    Virus Res; 2016 Dec; 226():85-92. PubMed ID: 27287711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of recombinant S1 domain of the porcine epidemic diarrhea virus spike protein.
    Oh J; Lee KW; Choi HW; Lee C
    Arch Virol; 2014 Nov; 159(11):2977-87. PubMed ID: 25008896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of sows with a dendritic cell-targeted porcine epidemic diarrhea virus S1 protein-based candidate vaccine reduced viral shedding but exacerbated gross pathological lesions in suckling neonatal piglets.
    Subramaniam S; Yugo DM; Heffron CL; Rogers AJ; Sooryanarain H; LeRoith T; Overend C; Cao D; Meng XJ
    J Gen Virol; 2018 Feb; 99(2):230-239. PubMed ID: 29300158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field trials evaluating the efficacy of porcine epidemic diarrhea vaccine, RNA (Harrisvaccine) in the Philippines.
    Sawattrakool K; Stott CJ; Bandalaria-Marca RD; Srijangwad A; Palabrica DJ; Nilubol D
    Trop Anim Health Prod; 2020 Sep; 52(5):2743-2747. PubMed ID: 32279241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenicity and immunogenicity of attenuated porcine epidemic diarrhea virus PC22A strain in conventional weaned pigs.
    Lin CM; Ghimire S; Hou Y; Boley P; Langel SN; Vlasova AN; Saif LJ; Wang Q
    BMC Vet Res; 2019 Jan; 15(1):26. PubMed ID: 30634958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and immunogenicity of recombinant swinepox virus expressing the truncated S protein of a novel isolate of porcine epidemic diarrhea virus.
    Yuan X; Lin H; Li B; He K; Fan H
    Arch Virol; 2017 Dec; 162(12):3779-3789. PubMed ID: 28916870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A newly isolated Chinese virulent genotype GIIb porcine epidemic diarrhea virus strain: Biological characteristics, pathogenicity and immune protective effects as an inactivated vaccine candidate.
    Liu X; Zhang Q; Zhang L; Zhou P; Yang J; Fang Y; Dong Z; Zhao D; Li W; Feng J; Cui B; Zhang Y; Wang Y
    Virus Res; 2019 Jan; 259():18-27. PubMed ID: 30342075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.